|
(Continued from page 41)
side their new school in the neighboring town of Monroe, where a middle school that had been shuttered for nearly two years was overhauled and renamed after their old school. Several officers guarded the entrance and checked IDs of parents dropping off children.
• ___
Incarcerated veterans train service dogs for disabled vets in Md. maximum-security prison
• CRESAPTOWN, Md. (AP) -- Hazard Wilson's new cellmate is a hairy bundle of energy whose playful zeal can't be contained by steel doors: a five-month-old golden retriever. Yardley is one of three canines assigned since September to inmates at a maximum-security prison in western Maryland for training as service dogs for disabled military veterans.
• The number of programs nationwide using inmates to train service dogs is growing, but the program at Western Correctional Institute might be the first to use incarcerated veterans to train dogs for other veterans.
• Professional trainers say prison-raised dogs tend to do better than those raised traditionally in foster homes, because puppies respond well to consistency and rigid schedules. That's just what they get in prison.
• It's not all work and no play.
• "I just love to see him be a puppy," said Wilson, 53, serving a life sentence for first-degree murder. "We're putting them through some very stringent training -- 90 percent of their time is training -- so it gives me great joy just see them romp and roll around and be puppies."
• ___
India's top court to decide fate of India's cheap, generic drugs used by millions of poor
• NEW DELHI (AP) -- From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines.
• The case -- involving Swiss drug maker Novartis AG's cancer drug Glivec -- pits aid groups that argue India plays a vital role as the pharmacy to the poor against drug companies that insist they need strong patents to make drug development profitable. A ruling by India's Supreme Court is expected in early 2013.
(Continued on page 43)
|
